Stay Alert for Situations Where Viberzi Should Be Avoided

May 2017

FDA is now warning to avoid the irritable bowel syndrome med, Viberzi (eluxadoline), in patients who don't have a gallbladder.

This is due to an increased risk of serious pancreatitis that can result in hospitalization or death in these patients.

Viberzi may cause digestive juices to back up into the pancreas. Patients without gallbladders can't store the excess fluid...and can end up with an inflamed pancreas.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Vaccines Watch for Confusing Abbreviations With Vaccines
Acetaminophen Look for Changes in Children's Chewable Acetaminophen Strengths
Respiratory & Allergy The New OTC Xyzal Allergy 24HR is the Same as Rx Xyzal
Rosacea Rhofade Cream for Rosacea Contains the Same Med as Some OTC Nasal Sprays
Overactive Bladder Expect a Shift Toward Fewer Oxybutynin IR Rxs for Overactive Bladder
Gastroenterology Stay Alert for Situations Where Viberzi Should Be Avoided
Cardiology Help Patients Avoid Problems if Fish Oil Supplements Are Used
Pregnancy Watch for Oral Antibiotics That Should Be Avoided During Pregnancy
Cholesterol Expect Repatha and Praluent to be Saved as Add-On Meds For High Cholesterol
Oral Health Alert the Pharmacist to Antibiotic Rxs That Are to Be Used Before Dental Work
Practice Prevent Errors Related to Rx Transfers or "Copies"

Stay Alert for Situations Where Viberzi Should Be Avoided

Practical advice for a better career, with unlimited access to CE

Table of Contents